Effects of Exercise on Alignment and Muscle Parameters in Forward Head Posture

November 27, 2023 updated by: Sibel Basaran, Cukurova University

The Effectiveness of Corrective Exercise Program on Alignment, Muscle Activation and Biomechanical Properties in Medical Students With Forward Head Posture

It is aimed to investigate the effect of corrective exercise program on alignment, muscle activation and biomechanical properties of muscles in medical students with forward head posture.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Forward head posture (FHP) is a common postural abnormality that can be seen in all age groups. It is characterized by the head position being forward relative to the neck in the sagittal plane. The anterior displacement of the head is mainly assessed through examination of the craniovertebral angle (CVA) and a CVA of ˂50° is described as a FHP. Therapeutic exercises have shown to be effective in FHP and related symptoms in many studies. One of the exercise programs applied is the corrective exercise program. Within the scope of this program, deep cervical flexor muscles and shoulder retractors are strengthened, cervical extensors and pectoral muscles are stretched. This exercise protocol has been reported to provide relief in neck pain, improvement in CVA and shoulder angle. However, the number of studies examining the effect of corrective exercise program for the affected muscle groups in FHP on muscle activation parameters is limited, and there is no study examining the effect on the biomechanical properties of the muscles.

In this study, it is aimed to investigate the effect of corrective exercise program on alignment, muscle activation and biomechanical properties of muscles in medical students with forward head posture.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Adana, Turkey, 01330
        • Çukurova University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Medical students with a Craniovertebral angle ˂ 50°

Exclusion Criteria:

  • History of chronic pain in cervical region
  • Presence of spinal deformity and malalignment
  • Disease, fracture or surgery affecting the spine-shoulder-pelvic region
  • Presence of malignancy
  • BMI outside the normal range
  • Presence of medical condition that prevents participation in physical exercise program
  • Presence of neuromuscular disease
  • Involvement in regular and professional sports activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Corrective Exercise
Selective corrective exercise program, 8 weeks

Strengthening exercises for deep cervical flexor muscles and shoulder retractors.

Stretching exercises for cervical extensors and pectoral muscles.

No Intervention: Control
Training for proper posture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craniovertebral angle
Time Frame: Day 0

The angle between the line connecting the seventh cervical vertebra and the tragus of right ear, and the horizontal line.

running in the sagittal place through the C7 process

Day 0
Craniovertebral angle
Time Frame: Week 8

The angle between the line connecting the seventh cervical vertebra and the tragus of right ear, and the horizontal line.

running in the sagittal place through the C7 process

Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface electromyography (EMG) amplitude (RMS)
Time Frame: Day 0
The activity levels of trapezius, sternocleidomastoid and pectoralis muscles will be measured with a wireless EMG system (Delsys, Inc, Boston, MA). The electrodes will be positioned on the belly of the muscle. The signals will be amplified and band-pass filtered (20-450 Hz) before being record digitally at 2000 samples per second, and then the root mean square (RMS) will be calculated. To normalize individual muscle contraction levels, we will use maneuvers of voluntary contractions.
Day 0
Surface electromyography (EMG) amplitude (RMS)
Time Frame: Week 8
The activity levels of trapezius, sternocleidomastoid and pectoralis muscles will be measured with a wireless EMG system (Delsys, Inc, Boston, MA). The electrodes will be positioned on the belly of the muscle. The signals will be amplified and band-pass filtered (20-450 Hz) before being record digitally at 2000 samples per second, and then the root mean square (RMS) will be calculated. To normalize individual muscle contraction levels, we will use maneuvers of voluntary contractions.
Week 8
Myotonometer measures (Muscle tone)
Time Frame: Day 0

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 Newton (N) force and frequency of 1Hertz (Hz) applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Oscillation Frequency [Hz]: Characterizes the tone (intrinsic tension) of a muscle in its passive or resting state.

Day 0
Myotonometer measures (Muscle stiffness)
Time Frame: Day 0

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 N force and frequency of 1Hz applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Dynamic Stiffness [N/m]: Characterises the resistance to a contraction or to an external force that deforms its initial shape.

Day 0
Myotonometer measures (Muscle elasticity)
Time Frame: Day 0

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 N force and frequency of 1Hz applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Logarithmic Decrement: Characterises elasticity.

Day 0
Myotonometer measures (Muscle tone)
Time Frame: Week 8

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 N force and frequency of 1Hz applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Ossilation Frequency [Hz]: Characterises the tone (intrinsic tension) of a muscle in its passive or resting state.

Week 8
Myotonometer measures (Muscle stiffness)
Time Frame: Week 8

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 N force and frequency of 1Hz applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Dynamic Stiffness [N/m]: Characterises the resistance to a contraction or to an external force that deforms its initial shape.

Week 8
Myotonometer measures (Muscle elasticity)
Time Frame: Week 8

The state of tension and biomechanical properties will be measured with a hand-held device (MyotonPro®, Myoton AS, Tallinn, Estonia). MyotonPro® displays the muscle mechanical properties by analyzing the oscillations of the myofascial tissue in response to the 10 short (15 ms) impulses, at 0.56 N and frequency of 1Hz applied by the probe of the device.

The superficial muscles (trapezius, sternocleidomastoid and pectoralis muscle) will be evaluated.

The device measures (computes simultaneously) the following parameters: Oscillation frequency (Hz), dynamic stiffness (N/m) and logarithmic decrement.

Logarithmic Decrement: Characterises elasticity.

Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aylin Sariyildiz, MD, Çukurova University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

October 1, 2023

Study Registration Dates

First Submitted

October 27, 2022

First Submitted That Met QC Criteria

November 11, 2022

First Posted (Actual)

November 16, 2022

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Forward Head Posture

Clinical Trials on Corrective exercise program

Subscribe